Skip to main content
. 2020 Dec;21(12):990–998. doi: 10.1631/jzus.B2000432

Fig. 3.

Fig. 3

Protein expression of DsbA-L enhanced by PPARγ agonists, RSG, and GW1929

(a) Representative image of the immunoblots of cell samples (50 μg); (b) Relative quantitative analysis of DsbA-L. PPARγ: peroxisome proliferator-activated receptor γ; DsbA-L: disulfide-bond A oxidoreductase-like protein; RSG: rosiglitazone. Data are shown as mean±standard deviation (SD) (n=3). ** P<0.01